MedPath

Anticoagulant Citrate Dextrose A ACD-A

Anticoagulant Citrate Dextrose Solution,Solution A, USP

Approved
Approval ID

b850deac-161f-4bb0-ac7f-bceac2a230c0

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 17, 2018

Manufacturers
FDA

Arteriocyte Medical Systems, Inc.

DUNS: 809012870

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Anticoagulant Citrate Dextrose A ACD-A

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code43203-852
Application NumberBA110057
Product Classification
M
Marketing Category
C73584
G
Generic Name
Anticoagulant Citrate Dextrose A ACD-A
Product Specifications
Route of AdministrationEXTRACORPOREAL
Effective DateDecember 17, 2018
FDA Product Classification

INGREDIENTS (4)

CITRIC ACID MONOHYDRATEActive
Quantity: 0.08 g in 10 mL
Code: 2968PHW8QP
Classification: ACTIM
DEXTROSE MONOHYDRATEActive
Quantity: 0.245 g in 10 mL
Code: LX22YL083G
Classification: ACTIB
WaterInactive
Quantity: 9.76 g in 10 mL
Code: 059QF0KO0R
Classification: IACT
SODIUM CITRATE, UNSPECIFIED FORMActive
Quantity: 0.220 g in 10 mL
Code: 1Q73Q2JULR
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Anticoagulant Citrate Dextrose A ACD-A - FDA Drug Approval Details